LEGAL PROCEEDINGS AND CONTINGENCIES (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended					9 Months Ended	12 Months Ended				1 Months Ended															9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013 Baraclude [Member]	Sep. 30, 2012 Baraclude [Member]	Sep. 30, 2013 Baraclude [Member]	Sep. 30, 2012 Baraclude [Member]	Sep. 30, 2013 Atripla Intellectual Property Litigation [Member]	Mar. 31, 2010 Atripla Intellectual Property Litigation [Member] lawsuits	Apr. 30, 2009 Atripla Intellectual Property Litigation [Member] patents	Sep. 30, 2013 Baraclude Intellectual Property Litigation [Member]	Dec. 31, 2012 Baraclude Intellectual Property Litigation [Member]	Aug. 31, 2010 Baraclude Intellectual Property Litigation [Member]	Nov. 30, 2010 Sprycel Intellectual Property Litigation [Member]	Sep. 30, 2010 Sprycel Intellectual Property Litigation [Member]	Nov. 30, 2008 Plavix Intellectual Property Litigation [Member]	Nov. 30, 2008 Remaining Apotex Matters Related To Plavix [Member]	Sep. 30, 2013 AWP Litigation [Member]	Sep. 30, 2010 AWP Litigation [Member]	Sep. 30, 2013 Qui Tam Litigation [Member]	Sep. 30, 2013 Plavix Product Liability Litigation [Member]	Sep. 30, 2013 Reglan Product Liability [Member]	Sep. 30, 2013 Hormone Replacement Therapy Product Liability [Member]	Apr. 30, 2013 Hormone Replacement Therapy Product Liability [Member]	Apr. 30, 2013 Byetta And Bydureon Product Liability Litigation [Member]	Sep. 30, 2013 BMS-986094 Product Liability [Member]	Sep. 30, 2013 Environmental Proceedings Cercla Matters [Member]	Sep. 30, 2013 Environmental Proceedings New Brunswick [Member]	Oct. 30, 2011 Environmental Proceedings New Brunswick [Member]	May 31, 2008 Environmental Proceedings New Brunswick [Member]	Sep. 30, 2013 Environmental Proceedings North Brunswick [Member] payment
Legal Proceedings And Contingencies [Line Items]
Number of patents owned										6	15
Number of patents challenged										8	2			1		4
Number of lawsuits										2									2						5	200	10		400	150	250
Number Of Interim Payments																																2
Number of patent infringement lawsuits										2					4
Settlement relating to efavirenz polymorph patents									2
Loss contingency, Estimate of possible loss																				$ 28								$ 67
Number of plaintiffs settled																										300
Number of current plaintiffs																						5,000	3,000			900
Number of sales representatives																					3
Litigation settlement, Gross																	60															4
Interest percentage on damages sought by third party																		1.00%
Net Sales	$ 4,065	$ 3,736	$ 11,944	$ 13,430	$ 378	$ 346	$ 1,115	$ 1,028				$ 208	$ 241
Number of plaintiffs settled in principle																									400
Additional number of plaintiffs settled in principle																								27
Number of claims remain outstanding																											2